Platelets and DAMI megakaryocytes possess β-secretase-like activity

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 5, 1999, Pages 507-515

  Abraham, Carmela R ^a,b   Marshall, Derek C L ^a,b   Tibbles, Heather E ^a,b   Otto, Kimberly ^a,b   Long, Heidi J ^a,b   Billingslea, Andrea M ^a,b   Hastey, Ryan ^a,b   Johnson, Robin ^a,b   Fine, Richard E ^a,b   Smith, Sally J ^a,b   Simons, Elizabeth R ^a,b   Davies, Theresa A ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Center for Health Quality Outcomes and Economic Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033135375     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90028-8     Document Type: Article

References (26)

1. 1. Tagliavini F, Ghiso J, Timmers WF, Giaccone G, Bugiani O, Frangione B. Coexistence of Alzheimer's amyloid precursor protein and amyloid in cerebral vessel walls. Lab Invest 1990;62:761-7.
2. 2. Selkoe DJ. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 1994;10:373-403.
3. 3. Selkoe DJ. Alzheimer's disease: a central role for amyloid. J Neuropathol Exp Neurol 1994;53:438-47.
4. 4. Bush AI, Martins RN, Rumble B, Moir R, Fuller S, Milward E, et al. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem 1990;265:15977-83.
5. 5. Van Nostrand W, Schmaier A, Farow J, Cines D, Cunningham D. Protease/nexin 2/amyloid β precursor protein in blood is a platelet-specific protein. Biochem Biophys Res Commun 1991;175:15-21.
6. 6. Chen M, Inestrosa N, Ross G, Fernandez H. Platelets are the primary source of amyloid β-peptide in human blood. Biochem Biophys Res Commun 1995;213:96-103.
7. 7. Frackowiak J, Zoltowska A, Wisniewski H. Non-fibrillar beta-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer's disease. J Neuropathol Exp Neurol 1994;53:637-45.
8. 8. Wisniewski H, Frackowiak J, Zoltowska A, Kim K. Vascular β-amyloid in Alzheimer's disease angiopathy is produced by proliferating and degenerating smooth muscle cells. Amyloid: Int J Exp Clin Invest 1994;1:8-16.
9. 9. Davies T, Fine R, Johnson R, Levesque C, Rathbun W, Seetoo K, et al. Non-age related differences in thrombin responses by platelets from male patients with advanced Alzheimer's disease. Biochem Biophys Res Commun 1993;194:537-43.
10. 10. Davies T, Long H, McMenamin M, Rathbun W, Seetoo K, Tibbles H, et al. Activated Alzheimer disease patients retain more beta-amyloid precursor protein. Neurobiol Aging 1997;18:147-53.
11. 11. Davies T, Long H, Rathbun W, Sgro K, Tibbles H, Smith S, et al. Platelets from patients with Alzheimer's disease or other dementias exhibit disease-specific and apolipoprotein E-correlatable defects. Amyloid: Int J Exp Clin Invest 1996;3:13-9.
12. 12. Davies TA, Long HJ, Tibbles HE, Sgro KR, Wells JM, Rathbun WH, et al. Moderate and advanced Alzheimer's patients exhibit platelet activation differences. Neurobiol Aging 1997;18:155-62.
13. 13. Papastoitsis G, Siman R, Scott R, Abraham CR. Identification of a metalloprotease from Alzheimer's disease brain able to degrade the β-amyloid precursor protein and generate amyloidogenic fragments. Biochemistry 1994;33:192-9.
14. 14. Conn KJ, Pietropaolo M, Ju ST, Abraham CR. Monoclon al antibodies against the human metalloprotease EC 3.4.24.15 label neurofibrillary tangles in Alzheimer's disease brain. J Neurochem 1996;66:2011-8.
15. 15. Slot F, Olsen AS, Rao PN, Abraham CR. Localization of human endopeptidase EC3.4.24.15 (THOP1) to chromosome 19pl3.3. Alzheimer's Reports 1998;1:327-31.
16. 16. Abraham CR, Driscoll J, Potter H, Van Nostrand WE, Tempst P. A calcium-activated protease from Alzheimer's disease brain cleaves at the N-terminus of the amyloid β-protein. Biochem Biophy Res Commun 1991;174:790-6.
17. 17. Razzaboni B, Papastoitisis G, Koo E, Abraham C. A calcium stimulated serine protease from monkey brain degrades the B-amyloid precursor protein. Brain Res 1992;589:207-16.
18. 18. Citron M, Diehl T, Capell A, Haass C, Teplow D, Selkoe D. Inhibition of amyloid β-protein production in neural cells by the serine protease inhibitor AEBSF. Neuron 1996;17:171-9.
19. 19. Greenberg SM, Chandrasekhar C, Golan DE, Handin RI. transforming growth factor β inhibits endomitosis in the DAMI™ human megakaryocytic cell line. Blood 1990;76:533-7.
20. 20. Davies TA, Billingslea A, Johnson R, Greenberg SM, Ortiz MF, Long HJ, el al. Stimulus responses and amyloid precursor processing in DAMI megakaryocytes. J Lab Lab Med 1997;130:21-32.
21. 21. DelBuono BJ, Luscinskas FW, Simons ER. Preparation and characterization of plasma membrane vesicles from human polymorphonuclear leukocytes. J Cell Physiol 1989;141:636-44.
22. 22. Abraham CR, Ben-Meir A, Tempst P. Facile and sensitive assay for monitoring proteolytic activities with defined specificities: studies on amyloid b-protein processing in Alzheimer's disease. Peptide Res 1990;3:211-5.
23. 23. Greenberg SM, Rosenthal DS, Greeley TA, Tantravahil R, Handin Tl. Characterization of a new megakaryocytic cell line: the DAMI™ cell. Blood 1988;72:1968-77.
24. 24. Greenberg SM, Chandraskhar C. Hematopoielic factor-induced synthesis of von Willebrand factor by the DAMI™ human megakaryoblastic cell line and by normal human megakaryocytes. Exp Hematol 1991;19:53-8.
25. 25. McDermott JR, Biggins JA, Gibson AM. Human brain peptidase activity with the specificity to generate the N-terminus of the Alzheimer β-amyloid protein from its precursor. Biochem Biophys Res Commun 1992;185:746-52.
26. 26. Tisljar U. Thimet oligopeptidase: a review of a thiol dependent metallo-endopeptidase also known as Pz-peptidase endopeptidase 24,15 and endo-oligopeptidase. J Biol Chem 1993;374:91-100.